Sprint Bioscience: Vinnova funding for fragment screening project - Redeye
Redeye comments on Sprint Bioscience's announcement that it has received Vinnova funding, together with MAX IV, for a joint research project in fragment-based drug discovery.
ANNONS
Redeye comments on Sprint Bioscience's announcement that it has received Vinnova funding, together with MAX IV, for a joint research project in fragment-based drug discovery.
